Skip to main content
. 2021 May 17;2021(5):CD013837. doi: 10.1002/14651858.CD013837.pub2

Comparison 4. Piperacillin compared with ampicillin plus amikacin.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
4.1 All‐cause mortality 1 396 Risk Ratio (M‐H, Fixed, 95% CI) 0.62 [0.35, 1.10]
4.2 Serious adverse events 1 396 Risk Ratio (M‐H, Fixed, 95% CI) 0.62 [0.35, 1.10]
4.3 Nephrotoxicity 1 396 Risk Ratio (M‐H, Fixed, 95% CI) 1.14 [0.80, 1.63]